tm logo
DEVELOPICK
Live/Registered
REGISTERED

on 22 Oct 2024

Last Applicant/ Owned by

Yeonsu-gu Incheon

KR

Serial Number

79365404 filed on 31st Jan 2023

Registration Number

7539787 registered on 22nd Oct 2024

in the Principal Register

Correspondent Address

Brian P. Gregg

Brian P. Gregg McNees Wallace & Nurick

Harrisburg, PA 17108

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

DEVELOPICK

Advisory services relating to technological research in the field of pharmaceutical manufacturing processes; advisory servicesrelating to scientific analysis in the field of nucleic acids; research relating to science, namely, scientific research; conducting oftechnical feasibility studies, namely, conducting of feasibility studies in the field of new technologies; multiple nucleic acid scientific Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Advisory services relating to technological research in the field of pharmaceutical manufacturing processes; advisory servicesrelating to scientific analysis in the field of nucleic acids; research relating to science, namely, scientific research; conducting oftechnical feasibility studies, namely, conducting of feasibility studies in the field of new technologies; multiple nucleic acid scientificanalysis; multiple nucleic check, namely, materials testing; analysis of materials; materials testing and evaluation; chemicalanalysis services for use in the testing of material; molecular analysis, namely, scientific analysis in the field of molecular biology;advisory services relating to biotechnology; technical management advisory services relating to biotechnology, namely, scientificresearch consulting, biotechnology consultancy services; biochemical analysis; advisory services relating to biochemistryresearch; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; design of new products forothers; technical advice relating to safety, namely, consumer product safety testing consultation; pharmaceutical research anddevelopment; pharmaceutical products evaluation; clinical research in the field of medicines; services for assessing the efficiencyof pharmaceuticals, namely, testing of pharmaceuticals; testing of raw materials; fusion protein analysis being testing of rawmaterials; computer programming services in the medical field; computer project management services relating to imagingmedical data; medicine research being medical research; scientific analysis and quality evaluation of medical productdevelopment; pharmaceutical technology advisory service, namely, computer technology consultancy; pharmaceutical productevaluation; providing scientific and medical information on the testing, inspection and research of medical products;pharmaceutical product evaluation; scientific laboratory services relating to the production of bispecific antibody; bispecificantibody drug development; double antibody reagent scientific research and development; evaluating of clinical trial progress,namely, conducting clinical trials for others; clinical research, namely, conducting clinical trials for others; evaluation of productdevelopment being product quality evaluation; product safety testing; quality assurance consultancy in the field ofpharmaceuticals; quality assessment being product testing; scientific research advisory services relating to chemical reagents;evaluation of chemical syntheses being product quality evaluation


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [040]
Treatment & Processing of Materials Services


Custom manufacture of polyclonal antibodies for pharmaceutical use; custom manufacture of biopharmaceuticals; processing ofbiopharmaceutical materials for others; treatment of biopharmaceutical materials; processing of plant hormones beingphytohormones; processing of medicinal materials; processing of pharmaceutical preparations; custom manufacture ofpharmaceuticals; processing of pharmaceuticals; custom manufacture of pharmaceutical bispecific antibodies; processing ofchemical reagents


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79365404

Mark Type

No Service Mark

Attorney Docket Number

No 34698-011#

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
22nd Oct 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
22nd Oct 2024REGISTERED-PRINCIPAL REGISTER
31st Aug 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14th Aug 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
14th Aug 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06th Aug 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06th Aug 2024PUBLISHED FOR OPPOSITION
17th Jul 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01st Jul 2024APPROVED FOR PUB - PRINCIPAL REGISTER
14th Jun 2024ASSIGNED TO LIE